Porocarcinoma; presentation and management, a meta-analysis of 453 cases.
Ann Med Surg (Lond) 2017;
20:74-79. [PMID:
28721214 PMCID:
PMC5499034 DOI:
10.1016/j.amsu.2017.06.027]
[Citation(s) in RCA: 68] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2017] [Revised: 06/18/2017] [Accepted: 06/18/2017] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND
porocarcinoma is a rare sort of skin cancer developing from sweat glands. Its clinical course and management are not well understood.
OBJECTIVES
the current meta-analysis is to address the presentation and management of porocarcinoma.
DATA SOURCES
Web of Science, PubMed, MEDLINE on OVID and Google scholar were searched for English-language studies published before December 1, 2016.
RESULTS
The review of literature revealed 453 cases. From which 222 (49%) cases were male and female were 231 (51%). The mean age was 67.57 years. The mean duration of presentation was 5.57 years ranging from 4 days to 60 years of age. The most common site of affection is the head and neck (39.9%) followed by lower extremity (33.9%). Mass and nodule are the most common modes of presentation. Metastasis occurred at presentation in 110 (31%) cases. The most common organ to which porocarcinoma metastizes is the nearby lymph node (57.7%).
CONCLUSIONS
Porocarcinoma is an aggressive skin cancer. Surgery is the main modality of treatment.
SYSTEMATIC REVIEW REGISTRATION NUMBER
reviewregistry233.
Collapse